None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 5-10 yr of both sexes. 2. Paediatric subjects will be selected irrespective of the socioeconomic status. 3. Those who are willing to participate in the study. 4. Written informed assent/consent is documented.
Exclusion criteria
Exclusion criteria: 1. Suffering from any other systemic illness and infectious disease, Severe malnutrition 2. Those who are not able to come for regular follow ups. 3. Those who are not willing to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Morbidity incidence reduction 2. Sustain of Seropositivity (Quantitative analysis) 3. Incidence/IgG positivity of COVID-19 in Seronegative participantsTimepoint: baseline, 03 months, 06 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Changes of Natural Killer cell activity 2. Changes of Cytokines (Inspection item pro-inflammatory cytokines-IL-1, IL-6, IL-18, IL-33, anti-inflammatory cytokines-IL-37, IL-38 TNF-α, Th1, Th2) 3. Changes in Serum IgA, IgE, IgM, and IgG responses 4. Changes in Biochemical parameters-CBC, Hb, ESR, LFT, KFT, Lipid profile, CRP, CD-4, CD-8 Cytotoxic T-cell function tests. 5. Improvement in Anthropometric parameters (Weight, Height, MUAC, Skinfold thickness)Timepoint: baseline, 03 months, 06 months | — |
Countries
India
Contacts
ALL INDIA INSTITUTE OF AYURVEDA, NEW DELHI